Theodore R. Miller
University of California, San Francisco
105 Papers
2.1K Citations
Theodore R. Miller is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Fine-needle aspiration & Biopsy. The author has an hindex of 38, co-authored 105 publications. Previous affiliations of Theodore R. Miller include Karolinska Institutet.
Chat about Author
Papers
What constitutes an adequate smear in fine-needle aspiration cytology of the breast?
TL;DR: This study supported an optimal balance between the competing need to minimize both insufficiency rates and false-negative rates by establishing adequacy at 6 or more cell clusters (cumulative total of all slides) or the presence of 10 (or more) intact bipolar cells per 10 medium-power fields.
14
•Journal Article
Aspiration cytology characterization of inflammatory masses.
K Bottles,Theodore R. Miller,Jeffrey Rb,Michael B. Cohen,Stoloff A,Martha Hales,Britt-Marie Ljung,Elizabeth Donegan +7 more
TL;DR: Fine-needle aspiration biopsy smears are useful in the workup of patients with abscesses and inflammatory masses and are classified into three groups, in which a causative organism was seen on the smear and cultured from a smear where organisms were not seen microscopically.
13
Malignant ganglioneuroma of the ganglion nodosum of the vagus nerve.
TL;DR: The patient is the youngest one in whom a malignant tumor of the nodose ganglion was successfully resected, and the case is the only one recorded in which no permanent defect persisted after resection of a ganglioneuroma of the ganglions nodosum of the vagus nerve.
10
Atypical melanocytic hyperplasia of the vagina.
TL;DR: Microscopic sections showed a resemblance to atypical melanocytic hyperplasia, which has been described as a possible precursor of malignant melanoma of the skin including the acral lentiginous form.
10
Fine-Needle Aspirates of Hepatocellular Carcinoma That Are Misclassified as Adenocarcinoma: Correlating Cytologic Features and Performance in the College of American Pathologists Nongynecologic Cytology Program
TL;DR: Correctly classifying hepatocellular carcinoma by cytology alone remains a significant challenge and people should support their interpretations of aspirations with either immunologic evidence, biopsy evidence, or review by an experienced cytopathologist.
9